Latest molecular research have provided lots of insights to the processes that govern the event and progression of CLL, which include quite a few novel mutated genes clustered in several purposeful pathways. The CLL epigenome is reprogrammed through the modulation of regulatory regions that look de novoEven with all recent therapeutic developments,